Basement Membrane Localized Tumor Cells Are Protected from HER2-Targeted Therapy In Vivo.

被引：0
|
作者：
Zoeller, J. J. [1 ]
Bronson, R. T. [1 ]
Gilmer, T. M. [1 ]
Selfors, L. M. [1 ]
Lu, Y. [1 ]
Mills, G. B. [1 ]
Brugge, J. S. [1 ]
机构：
[1] Harvard Univ, Sch Med, Boston, MA USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-S5-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
S5-3
引用
收藏
页数：1
相关论文
共 50 条
  • [41] In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody
    Ding, Ning
    Sano, Kohei
    Kanazaki, Kengo
    Ohashi, Manami
    Deguchi, Jun
    Kanada, Yuko
    Ono, Masahiro
    Saji, Hideo
    MOLECULAR IMAGING AND BIOLOGY, 2016, 18 (06) : 870 - 876
  • [42] HER3 mediates acquired resistance to HER2-targeted therapy in esophageal adenocarcinoma
    Ebbing, Eva A.
    Medema, Jan Paul
    Meijer, Sybren L.
    Krishnadath, Kausilia K.
    Henegouwen, Mark I. van Berge
    Bijlsma, Maarten F.
    van Laarhoven, Hanneke W. M.
    CANCER RESEARCH, 2015, 75
  • [43] Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation
    Fernandez-Nogueira, Patricia
    Mancino, Mario
    Fuster, Gemma
    Lopez-Plana, Anna
    Jauregui, Patricia
    Almendro, Vanesa
    Enreig, Estel
    Menendez, Silvia
    Rojo, Federico
    Noguera-Castells, Aleix
    Bill, Anke
    Gaither, L. Alex
    Serrano, Laia
    Recalde-Percaz, Leire
    Moragas, Nuria
    Alonso, Raul
    Ametller, Elisabet
    Rovira, Ana
    Lluch, Ana
    Albanell, Joan
    Gascon, Pere
    Bragado, Paloma
    CLINICAL CANCER RESEARCH, 2020, 26 (06) : 1432 - 1448
  • [44] In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody
    Ning Ding
    Kohei Sano
    Kengo Kanazaki
    Manami Ohashi
    Jun Deguchi
    Yuko Kanada
    Masahiro Ono
    Hideo Saji
    Molecular Imaging and Biology, 2016, 18 : 870 - 876
  • [45] Resistance mechanisms to HER2-targeted therapy in gastroesophageal adenocarcinoma: A systematic review
    Blange, Dionne
    Stroes, Charlotte I.
    Derks, Sarah
    Bijlsma, Maarten F.
    van Laarhoven, Hanneke W. M.
    CANCER TREATMENT REVIEWS, 2022, 108
  • [46] TLR2 agonist PSK activates NK cells and enhances the anti-tumor effect of HER2-targeted monoclonal antibody therapy
    Lu, Hailing
    Yang, Yi
    Gad, Ekram
    Disis, Mary L.
    CANCER RESEARCH, 2011, 71
  • [47] Novel HER2-targeted gold nanoparticles; integration of antibody therapy and nanotechnology
    Kubota, Tetsushi
    Kuroda, Shinji
    Morihiro, Toshiaki
    Tazawa, Hiroshi
    Kagawa, Shunsuke
    Fujiwara, Toshiyoshi
    CANCER RESEARCH, 2016, 76
  • [48] HER2-targeted therapy influences CTC status in metastatic breast cancer
    Thomas M. Deutsch
    Sabine Riethdorf
    Carlo Fremd
    Manuel Feisst
    Juliane Nees
    Chiara Fischer
    Andreas D. Hartkopf
    Klaus Pantel
    Andreas Trumpp
    Florian Schütz
    Andreas Schneeweiss
    Markus Wallwiener
    Breast Cancer Research and Treatment, 2020, 182 : 127 - 136
  • [49] Access to HER2-targeted therapy at a tertiary care center in India: An evolution
    Nair, Nita S.
    Gupta, Sudeep
    Ghosh, Jaya
    Desai, Sangeeta
    Parmar, Vani
    Shet, Tanuja
    Chitkara, Garvit
    Siddique, Shabina
    Badwe, Rajendra A.
    INDIAN JOURNAL OF CANCER, 2022, 59 (03) : 375 - 379
  • [50] Tumor-type agnostic, targeted therapies make a new step forward: The first tumor-agnostic approval of a HER2-targeted therapy
    Vranic, Semir
    Gatalica, Zoran
    BIOMOLECULES AND BIOMEDICINE, 2024, 24 (04): : 673 - 675
12345